MEP38808A - Use of lh in controlled ovarian hyperstimulation - Google Patents
Use of lh in controlled ovarian hyperstimulationInfo
- Publication number
- MEP38808A MEP38808A MEP-388/08A MEP38808A MEP38808A ME P38808 A MEP38808 A ME P38808A ME P38808 A MEP38808 A ME P38808A ME P38808 A MEP38808 A ME P38808A
- Authority
- ME
- Montenegro
- Prior art keywords
- ovarian hyperstimulation
- controlled ovarian
- coh
- controlled
- folliculogenesis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Ovaj pronalazak opisuje jednu novu upotrebu LH, i analoga koji imaju aktivnost LH, da se pomogne foliklulogeneza kod kontrolisane hiperstimulacije ovarijma (COH), gdje se LH ili njegov analog daju tokom perioda uvođenja koji traje od prvog dana do oko četvrtog stimulatorne faze u COH.The present invention describes a novel use of LH, and analogs having LH activity, to aid folliculogenesis in controlled ovarian hyperstimulation (COH), wherein LH or an analog thereof is administered during the introduction period lasting from the first day to about the fourth stimulating phase in COH.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01307755 | 2001-09-12 | ||
| PCT/GB2002/004147 WO2003022301A2 (en) | 2001-09-12 | 2002-09-12 | Use of lh in controlled ovarian hyperstimulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MEP38808A true MEP38808A (en) | 2011-02-10 |
Family
ID=8182260
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MEP-388/08A MEP38808A (en) | 2001-09-12 | 2002-09-12 | Use of lh in controlled ovarian hyperstimulation |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US7341989B2 (en) |
| EP (1) | EP1434600B1 (en) |
| JP (1) | JP2005504072A (en) |
| KR (1) | KR20040032953A (en) |
| CN (1) | CN1302806C (en) |
| AR (1) | AR036591A1 (en) |
| AT (1) | ATE427755T1 (en) |
| AU (1) | AU2002331939B2 (en) |
| BR (1) | BR0212502A (en) |
| CA (1) | CA2457067A1 (en) |
| CY (1) | CY1110487T1 (en) |
| DE (1) | DE60231892D1 (en) |
| DK (1) | DK1434600T3 (en) |
| EA (1) | EA009210B1 (en) |
| ES (1) | ES2322136T3 (en) |
| HK (1) | HK1067866A1 (en) |
| HR (1) | HRP20040070A2 (en) |
| IL (1) | IL160781A0 (en) |
| ME (1) | MEP38808A (en) |
| MX (1) | MXPA04002125A (en) |
| NO (1) | NO327154B1 (en) |
| PL (1) | PL205472B1 (en) |
| PT (1) | PT1434600E (en) |
| RS (1) | RS51505B (en) |
| SI (1) | SI1434600T1 (en) |
| UA (1) | UA78970C2 (en) |
| WO (1) | WO2003022301A2 (en) |
| ZA (1) | ZA200401008B (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS105004A (en) * | 2002-06-07 | 2007-02-05 | Ares Trading S.A., | Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method |
| US20040248784A1 (en) * | 2003-06-03 | 2004-12-09 | Marco Filicori | Unitary combinations of FSH and hCG |
| CN102296047B (en) * | 2011-08-13 | 2013-03-13 | 新疆农垦科学院 | In vitro embryo production method by utilization of lamb superovulation oocytes |
| US9216037B2 (en) | 2013-06-21 | 2015-12-22 | Previvo Genetics, Llc | Uterine lavage for embryo retrieval |
| US20150272622A1 (en) | 2011-12-22 | 2015-10-01 | Previvo Genetics, Llc | Recovery and processing of human embryos formed in vivo |
| US9282995B2 (en) * | 2011-12-22 | 2016-03-15 | Previvo Genetics, Llc | Recovery and processing of human embryos formed in vivo |
| EP2968391A1 (en) | 2013-03-13 | 2016-01-20 | Moderna Therapeutics, Inc. | Long-lived polynucleotide molecules |
| RU2629871C1 (en) * | 2016-03-22 | 2017-09-04 | Сергей Михайлович Юдин | Preparation for folliculogenesis stimulation and method for its application |
| IT202000022015A1 (en) * | 2020-09-18 | 2022-03-18 | Marca Antonio La | NEW USE OF LUTEINIZING HORMONE |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4589402A (en) | 1984-07-26 | 1986-05-20 | Serono Laboratories, Inc. | Method of in vitro fertilization |
| IT1250075B (en) * | 1991-12-18 | 1995-03-30 | Serono Cesare Ist Ricerca | PHARMACEUTICAL COMPOSITIONS CONTAINING GONADOTROPINE. |
| US7695721B1 (en) | 1999-05-07 | 2010-04-13 | Merck Serono S.A. | Gonadotrophins in the treatment anovulatory women |
-
2002
- 2002-09-12 PT PT02767637T patent/PT1434600E/en unknown
- 2002-09-12 EA EA200400428A patent/EA009210B1/en not_active IP Right Cessation
- 2002-09-12 AR ARP020103455A patent/AR036591A1/en not_active Application Discontinuation
- 2002-09-12 EP EP02767637A patent/EP1434600B1/en not_active Revoked
- 2002-09-12 SI SI200230815T patent/SI1434600T1/en unknown
- 2002-09-12 US US10/487,423 patent/US7341989B2/en not_active Expired - Fee Related
- 2002-09-12 DE DE60231892T patent/DE60231892D1/en not_active Expired - Lifetime
- 2002-09-12 MX MXPA04002125A patent/MXPA04002125A/en active IP Right Grant
- 2002-09-12 CN CNB028175743A patent/CN1302806C/en not_active Expired - Fee Related
- 2002-09-12 KR KR10-2004-7002589A patent/KR20040032953A/en not_active Application Discontinuation
- 2002-09-12 ES ES02767637T patent/ES2322136T3/en not_active Expired - Lifetime
- 2002-09-12 AT AT02767637T patent/ATE427755T1/en active
- 2002-09-12 JP JP2003526429A patent/JP2005504072A/en active Pending
- 2002-09-12 WO PCT/GB2002/004147 patent/WO2003022301A2/en active Application Filing
- 2002-09-12 DK DK02767637T patent/DK1434600T3/en active
- 2002-09-12 IL IL16078102A patent/IL160781A0/en unknown
- 2002-09-12 AU AU2002331939A patent/AU2002331939B2/en not_active Ceased
- 2002-09-12 CA CA002457067A patent/CA2457067A1/en not_active Withdrawn
- 2002-09-12 RS YUP-212/04A patent/RS51505B/en unknown
- 2002-09-12 BR BR0212502-1A patent/BR0212502A/en not_active Application Discontinuation
- 2002-09-12 ME MEP-388/08A patent/MEP38808A/en unknown
- 2002-09-12 PL PL367343A patent/PL205472B1/en unknown
- 2002-12-09 UA UA2004031858A patent/UA78970C2/en unknown
-
2004
- 2004-01-23 HR HR20040070A patent/HRP20040070A2/en not_active Application Discontinuation
- 2004-02-06 ZA ZA2004/01008A patent/ZA200401008B/en unknown
- 2004-03-08 NO NO20040990A patent/NO327154B1/en not_active IP Right Cessation
-
2005
- 2005-02-22 HK HK05101453A patent/HK1067866A1/en not_active IP Right Cessation
-
2009
- 2009-06-30 CY CY20091100694T patent/CY1110487T1/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2130574T3 (en) | CYTOKINE RESTRICTION AGENTS. | |
| MEP38808A (en) | Use of lh in controlled ovarian hyperstimulation | |
| BR9106702A (en) | ANALOG OF OLIGONUCLEOTIDEOS AND PROCESSES TO MODULATE THE PRODUCTION OF A PROTEIN BY AN ORGANISM AND TO TREAT AN ORGANISM | |
| BR9006729A (en) | REINFORCEMENT AND SUPPORT DEVICE FOR THE ROOF ROTATORS OF A HUMAN SHOULDER JOINT | |
| HUP0003349A2 (en) | Peptide parathyroid hormone analogs, pharmaceutical compositions comprising thereof and their use | |
| DE69839812D1 (en) | ANALOGUE OF HUMAN INTERFERON ALPHA WITH LOW TOXICITY | |
| DE69930758D1 (en) | USE OF DAPTOMYCIN | |
| DE69033521T2 (en) | USE OF ARGININE AS AN IMMUNE STIMULATOR | |
| KR950031060A (en) | Pharmaceutical composition for the treatment of osteoporosis | |
| PT1001802E (en) | COMBINED PHARMACEUTICAL PREPARATION UNDERSTANDING PARTIROID HORMONE AND A REBORN INHIBITOR OSSEA | |
| EA200801714A1 (en) | NONTOXIC FOR NERVOUS TISSUE PLASMINOGEN-ACTIVATING FACTORS FOR TREATMENT OF STROKE | |
| DK0678013T3 (en) | Preparations for the treatment of hair | |
| ES2135398T3 (en) | COMPOUND AND COMPOSITIONS OF INHIBITION OF BONE RESORPTION. | |
| RS50805B (en) | Use of fsh for treating infertility | |
| DE69630583D1 (en) | PEPTIDE, BRONCHODILATOR AND AGENT TO IMPROVE THE BLOOD FLOW | |
| ATE398134T1 (en) | NEW ANALOGUE OF NITROBENZYLTHIOINOSINE | |
| ATE433749T1 (en) | NEW USE OF RAPAMYCIN AND STRUCTURAL ANALOGS THEREOF | |
| KR950013519A (en) | Medicines for preventing and treating fractures | |
| ATE374202T1 (en) | NEW ANALOGUE OF NITROBENZYLTHIOINOSINE | |
| PT1007085E (en) | USES OF GROWTH HORMONE IN COMPOSITIONS FOR THE TREATMENT OF INSULIN RESISTANCE IN THE HEART | |
| EA201000501A1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING NO NEUROQUATIC PRESENTING PLASMINOGEN ACTIVATOR FOR TREATMENT | |
| BR0212274A (en) | Use of non-feminizing estrogens as retinoprotective agents for the treatment of glaucoma. | |
| ATE412669T1 (en) | CALICITONIN ANALOGS WITH HIGHLY INCREASED HYPOCALCEMIC EFFECTS IN VIVO | |
| ATE196465T1 (en) | ANALOGUE OF DIFLUORO-STATON | |
| LT2002105A (en) | Novel use of siberian fir oil |